| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
Archive
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
ABI analysis asset allocation Basel III bonds Comment Council counter-cyclical premium Data EIOPA Equivalence European Commission European Parliament Extrapolation FSA Groups IAIS Illiquidity Premium implementation Insurance Europe Interim measures Internal model Investment Level 2 look-through LTG Matching adjustment MCR Omnibus II ORSA Pillar I Pillar II PIllar III Proportionality QRTs Regulation Reporting SCR SFCR Solvency II standard formula Stress test timeline trilogue XBRL
Copyright © 2021 Solvency II Wire
